Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:58 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 913–936 of 2,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Neurodevelopmental Disorder Clear all

Conditions: Autism Spectrum Disorder
Interventions: Pivotal Response Treatment; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 4 Years to 7 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Developmental Delay
Interventions: Caregiver coaching; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 12 Months to 6 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Autism, Autism Spectrum Disorder (ASD, Asperger's Disorder, Pervasive Developmental Disorder (PDD-NOS)
Interventions: Cognitive-Behavioral Therapy (CBT) for Irritability; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 9 Years to 16 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Autism Spectrum Disorder (ASD)
Interventions: KZ101, Placebo; Drug
Lead sponsor: Children's Hospital of Orange County; Other
Eligibility: 5 Years to 14 Years · Male only
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Orange, California • Baltimore, Maryland

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Mobile behavioral parent training (mBPT), In the moment feedback, In the moment suggestions; Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 7 Years to 12 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Autism
Interventions: FANS-EI, Early Intervention; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 12 Months and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Sacramento, California

Conditions: ADHD
Interventions: Focalin XR; Drug
Lead sponsor: Novartis; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: Intermittent Theta-Burst Stimulation, Sham Stimulation; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Covid19, Intellectual Disability, Developmental Disability, Child Development Disorder
Interventions: Standard Messaging, Enhanced Messaging, COVID-19 Testing, Focus Groups, Fuzzy Cognitive Mapping; Behavioral · Diagnostic Test
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 5 Years to 90 Years
Enrollment: 1,143 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 3
States / cities: Baltimore, Maryland • Kansas City, Missouri • St Louis, Missouri

Conditions: Autism
Interventions: Valproate; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 6 Years to 21 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: ADHD
Interventions: Vyvanse (lisdexamfetamine dimesylate), Placebo; Drug
Lead sponsor: Shire; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 9
States / cities: Little Rock, Arkansas • Irvine, California • Wildomar, California + 5 more

Conditions: Attention-Deficit Hyperactivity Disorder
Interventions: Active eTNS, Sham eTNS; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 7 Years to 12 Years
Enrollment: 218 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Los Angeles, California • Seattle, Washington

Conditions: Brain Injuries, Cerebral Palsy
Interventions: magnesium sulfate; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 0 Years to 12 Hours
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1987 – 2003
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Tourette Syndrome, Apathy
Interventions: Children's Motivation Scale, Yale Global Tic Severity Scale (YGTSS), Studies Depression Scale for Children (CES-DC), Gilles de la Tourette Syndrome Quality Of Life scale, Demographic Data; Other
Lead sponsor: University of Florida; Other
Eligibility: 12 Years to 16 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Autism Spectrum Disorder
Interventions: No Intervention Provided; Other
Lead sponsor: Intelligent Hearing Systems; Industry
Eligibility: 42 Months to 54 Months
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Developmental and Epileptic Encephalopathy
Interventions: LP352; Drug
Lead sponsor: Longboard Pharmaceuticals; Industry
Eligibility: 2 Years to 66 Years
Enrollment: 324 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 21
States / cities: Little Rock, Arkansas • Los Angeles, California • Palo Alto, California + 17 more

Conditions: Autism Spectrum Disorder
Interventions: STEPS, Services as usual (SAU); Behavioral
Lead sponsor: University of Alabama, Tuscaloosa; Other
Eligibility: 16 Years to 25 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Tuscaloosa, Alabama

Conditions: Autism, Autistic Disorder, Child Development Disorders, Pervasive, Gastrointestinal Diseases, Signs and Symptoms, Digestive
Interventions: Oralgam (human immunoglobulin); Drug
Lead sponsor: PediaMed Pharmaceuticals; Industry
Eligibility: 2 Years to 18 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 22
States / cities: Phoenix, Arizona • Sacramento, California • Gainesville, Florida + 17 more

Conditions: Autism Spectrum Disorder, Typical Development
Interventions: tDCS, Autism Training; Device · Behavioral
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 18 Years to 21 Years · Male only
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Richardson, Texas

Conditions: Developmental Delay
Interventions: Family Navigator Intervention; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 3 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Cerebral Palsy, Spinal Muscular Atrophy, Spinal Cord Injuries, Spina Bifida, Development Delay, Genetic Disease
Interventions: Power Wheelchair Standing Device; Device
Lead sponsor: Grand Valley State University; Other
Eligibility: 5 Years to 17 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: Guanfacine, Methylphenidate (MPH); Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 7 Years to 14 Years
Enrollment: 212 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Tourette Syndrome
Interventions: Therapist-directed Behavioral Therapy, Home-based DVD Therapy; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 7 Years to 13 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Dexmethylphenidate, Mixed Amphetamine Salts, ER, placebo; Drug
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 9 Years to 17 Years
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 2
States / cities: Chicago, Illinois • Northbrook, Illinois

Search by objective public record fields.

Tracking Intervention Effects With Eye Tracking

Coaching in Early Development Project

Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder

Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population With Autism Spectrum Disorder (ASD)

Mobile Behavioral Parent Training for Childhood ADHD: A Micro-randomized Trial

Improving Caregiver Engagement in Early Interventions

Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD

Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD

Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic

Valproate Response in Aggressive Autistic Adolescents

A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)

Efficacy of Trigeminal Nerve Stimulation for ADHD

Magnesium Sulfate to Prevent Brain Injury in Premature Infants

Apathy in Tourette Syndrome and Changes in Quality of Life

Screening for Autism Spectrum Disorders Using Auditory Brainstem Responses

A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)

STEPS Implementation Trial

Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism

Improving Social Interaction for Adolescents With Autism During the Transition to Adulthood

Head Start Family Navigator Intervention

Pediatric Powered Wheelchair Standing Devices: An Exploratory Study

Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder

Behavioral Therapy for Tourette Syndrome

Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR